6Roccard AM, Sacco A, Chen C, et al. MicroRNA expression in the biology,prognosis and therapy of Waldestrom macroglobulinemia [ J ]. Blood ,2009,113 ( 18 ) :4391-4402.
7Harada Y,Ido N, Okada T, et al. Nephrotic syndrome caused by protein thrombi in glomerulocallary lumen in Waldenstrom's macroglobulinemia [ J ]. Br J Haematol,2000,110 (4) :880-883.
4Gertz MA, bler|ini G ,Treon SP. Amyloidosis and Waldenstr~m's macro- globulinemia[J]. Hematology Am Soc Hematol Educ Program, 2004 : 257-282.
5Treon SP. How I treat Waldenstrtim macroglobulinemia[J]. Blood, 2015, 126(6) :721-732.
6Herrinton L J, Weiss NS. Incidence of Waldenstrom's macroglobulinemia[J]. Blood, 1993, 82(10): 3148-3150.
7Konoplev S, Medeiros LJ, Bueso - Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/ Waldenstrom maeroglobulinemia[J]. Am J Clin Pathol, 2005, 124 (3): 414-420. DOI: IO.1309/3G1X-DXOD-VHBN-VKB4.
8Hamidou MA, E1 KD, Audrain M, et al. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia[J]. Ann Rheum Dis, 2001, 60(3): 293-295.
9Hamidou MA, Derenne S, Audrain MA, et al. Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. A prospective study [J]. Rheumatology (Oxford), 2000, 39(4): 417-420.
10Fain O, Hamidou M, Cacoub P, et al. Vasculitides associated with malignancies: analysis of sixty patients[J]. Arthritis Rheum, 2007, 57(8): 1473-1480. DOI: 10.1002/art.23085.
